(Q49968961)

English

Comparative study of cytogenetic response evaluated by conventional banding analysis and fluorescence in situ hybridization in chronic myeloid leukemia patients during tyrosine kinase inhibitor treatment

scientific article published in November 2017

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29224320

Comparative study of cytogenetic response evaluated by conventional banding analysis and fluorescence in situ hybridization in chronic myeloid leukemia patients during tyrosine kinase inhibitor treatment (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29224320

chronic myeloid leukemia

0 references

author name string

Z Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29224320

N Li

2

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29224320

L Gao

3

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29224320

L Feng

4

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29224320

Y Z Qin

5

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29224320

H Dang

6

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29224320

Y Shi

7

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29224320

Q He

8

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29224320

Q Jiang

9

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29224320

H Jiang

10

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29224320

Y Y Lai

11

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29224320

language of work or name

0 references

publication date

1 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29224320

Chinese Journal of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29224320

38

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29224320

11

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29224320

962-967

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29224320

Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/29224320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Persistence of BCR-ABL genomic rearrangement in chronic myeloid leukemia patients in complete and sustained cytogenetic remission after interferon-alpha therapy or allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/29224320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29224320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chromosomal abnormalities in Philadelphia chromosome negative metaphases appearing during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29224320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of bone marrow high mitotic index metaphase fluorescence in situ hybridization to peripheral blood and bone marrow real time quantitative polymerase chain reaction on the International Scale for detecting residual disease in chronic myelo

1 reference

https://pubmed.ncbi.nlm.nih.gov/29224320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29224320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response: a study of the GIMEMA CML WP.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29224320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Front-line and salvage therapies with tyrosine kinase inhibitors and other treatments in chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/29224320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Guideline for management of chronic myeloid leukemia(2013)]

1 reference

https://pubmed.ncbi.nlm.nih.gov/29224320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29224320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Which method better evaluates the molecular response in newly diagnosed chronic phase chronic myeloid leukemia patients with imatinib treatment, BCR-ABL(IS) or log reduction from the baseline level?

1 reference

https://pubmed.ncbi.nlm.nih.gov/29224320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Comparison of simultaneous bone marrow cytogenetic and peripheral blood molecular responses in chronic myeloid leukemia].

1 reference

https://pubmed.ncbi.nlm.nih.gov/29224320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3760/CMA.J.ISSN.0253-2727.2017.11.012

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29224320

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29224320

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49968961&oldid=2233829612"